Latest / The Best of the Money Show / SA govt turns to private sector to boost FMD vaccine supply
Transcript
- 0:00Speaker 1: Well, South Africa has been battling with the provision of
- 0:02Speaker 1: vaccines to beat foot and mouth disease. In response, private
- 0:06Speaker 1: manufacturers are now being brought in. Qualifying companies will be
- 0:10Speaker 1: allowed to use the Agricultural Research Council's intellectual property to
- 0:16Speaker 1: manufacture its locally developed vaccine at scale. Now, the council
- 0:20Speaker 1: has only been able to produce around 20,000 doses worldwide.
- 0:24Speaker 1: while the country needs about 2.5 million doses a month.
- 0:28Speaker 1: So you're saying to yourself, oh, how does this work? Well,
- 0:30Speaker 1: more than 21 million doses have been imported or produced
- 0:34Speaker 1: so far this year. And on the line is agricultural economist,
- 0:39Speaker 1: Tabile Nkunjana. Tabile, hi, good evening. Welcome to The Money Show.
- 0:43Speaker 2: Good morning to you, Ray, and the listeners at home.
- 0:46Speaker 2: Thanks for having me on the show.
- 0:47Speaker 1: It's good to have you. It's Ray here with you
- 0:49Speaker 1: this evening. Now, Tabile, question to you. I mean, the
- 0:52Speaker 1: intellectual property market, Using that, is it really going to
- 0:56Speaker 1: make a difference? I mean, this is just the latest
- 0:59Speaker 1: twist in the whole thing that is foot and mouth disease.
- 1:03Speaker 1: What are you seeing?
- 1:03Speaker 2: Yeah, I think, Ray, what is important, it has been
- 1:08Speaker 2: the fact that as much as the ARC is doing
- 1:14Speaker 2: a wonderful job in producing the vaccines that we need,
- 1:18Speaker 2: but the bigger issue is the fact that they are
- 1:20Speaker 2: overwhelmed in terms of the numbers that we need. You
- 1:22Speaker 2: did mention that a few weeks we are producing between
- 1:25Speaker 2: 15,000 to 20,000. That is very small compared to the
- 1:28Speaker 2: need of this. So therefore, now using the IV that
- 1:33Speaker 2: is available from the ARC, I think that is important
- 1:36Speaker 2: to note the fact that the ARC is going to
- 1:38Speaker 2: remain the owner of it. The companies that are going
- 1:40Speaker 2: to work with them, they're going to be working on
- 1:43Speaker 2: the side of a license kind of environment. So meaning
- 1:45Speaker 2: as much as the private sector is going to be involved,
- 1:47Speaker 2: what they are needed for is just to boost the
- 1:49Speaker 2: numbers that we have been producing per week so that
- 1:52Speaker 2: we can be able to sort of increase our local production,
- 1:57Speaker 2: because the issue of buying outside, it is another tedious
- 2:00Speaker 2: process that somehow it does not really match the strains
- 2:05Speaker 2: that we have in South Africa. So now with ARC
- 2:08Speaker 2: having one of the effective vaccines, so working with these
- 2:11Speaker 2: companies and then, of course, working within the teams that
- 2:13Speaker 2: are within that, then it's going to be best not
- 2:15Speaker 2: for only government, also for the private sector, because what
- 2:18Speaker 2: is important here is it's not who is going to
- 2:20Speaker 2: be producing this vaccine. but it is what is going
- 2:23Speaker 2: to be needed and also the job that needs to
- 2:27Speaker 2: be done, which is to prevent the damage that this
- 2:30Speaker 2: disease has caused into the slide success in South Africa.
- 2:33Speaker 1: Yeah. It's just interesting. I mean, we had John Stianhazen.
- 2:38Speaker 1: He was the minister. He was replaced by Willi Orkamp.
- 2:42Speaker 1: How do you see the new agriculture minister interfering in
- 2:46Speaker 1: making sure that we're putting our best foot forward in
- 2:49Speaker 1: stopping foot and mouth disease?
- 2:51Speaker 2: Yeah. I think, Ray, what is important now, as much
- 2:55Speaker 2: as there's been a lot of comparison between Minister John,
- 2:58Speaker 2: which I would say that he has done a wonderful job,
- 3:01Speaker 2: except that the issue was the fact that at a
- 3:04Speaker 2: scale that we are dealing with this foot and mouth disease,
- 3:07Speaker 2: it is not something that we have done before. So therefore,
- 3:10Speaker 2: any minister that could have been in his shoes at
- 3:13Speaker 2: that time, he was not going to be as effective.
- 3:15Speaker 2: In fact, if I can tell you that even the
- 3:17Speaker 2: ARC now that we are going to be working, that
- 3:19Speaker 2: the private sector is going to be working with, You know,
- 3:22Speaker 2: it is Minister John Wayne in the office was the
- 3:26Speaker 2: one that pushed so that ARC can be able to
- 3:31Speaker 2: produce this for himself. So therefore, the two ministers, I
- 3:34Speaker 2: would say that they're kind of somehow complementing each other.
- 3:37Speaker 2: So I don't want to really say you can just
- 3:40Speaker 2: point fingers, because even then, there are certain people that
- 3:43Speaker 2: are pointing fingers to other individuals, but this is something
- 3:46Speaker 2: that we have never dealt with in this case. So therefore,
- 3:49Speaker 2: it was never going to be a good idea to
- 3:50Speaker 2: paint anyone in terms of why we have failed or
- 3:53Speaker 2: there's been an issue. Because even before he came to
- 3:56Speaker 2: the office, we were dealing with the foot and mouth disease,
- 3:58Speaker 2: but just that the scale that it just kind of
- 4:01Speaker 2: came out about, it was different. And therefore it was
- 4:04Speaker 2: a problem, not only for him, but for anyone that
- 4:06Speaker 2: was closer with him and so forth. Yeah.
- 4:09Speaker 1: Dabina, where are we in the fight, in the fight
- 4:12Speaker 1: against foot and mouth disease? Are we getting to herd immunity?
- 4:16Speaker 1: What do your figures say to you? I mean, many
- 4:19Speaker 1: farmers have taken on massive losses.
- 4:21Speaker 2: What do you see? Yeah, that's one thing that has
- 4:25Speaker 2: been important. I think that's something that actually we should
- 4:28Speaker 2: be focusing on in terms of how we're doing and
- 4:31Speaker 2: what is the progress. I can tell you that as
- 4:33Speaker 2: much as we have seen a lot of revamp in
- 4:36Speaker 2: terms of the doses that are going out, a whole
- 4:40Speaker 2: lot of vaccinations going across the key areas that get
- 4:44Speaker 2: to be infected. So as things turn now, we have
- 4:49Speaker 2: had already the doses that have been imported they've already
- 4:52Speaker 2: been secured and all that. So therefore, there has been
- 4:57Speaker 2: some really progress in terms of those vaccines. But now
- 5:01Speaker 2: in terms of dealing with the disease itself, this stage
- 5:04Speaker 2: is quite early to say this is what has been
- 5:08Speaker 2: the result. But at least from what we are seeing
- 5:10Speaker 2: from the farmers' point of view is that the numbers
- 5:13Speaker 2: of the supply of the meat, the lost slaughter numbers,
- 5:16Speaker 2: they are telling us that we have seen an increase
- 5:18Speaker 2: in that. And that is positive because actually, even if
- 5:21Speaker 2: you have to look into the food inflation, the meat
- 5:23Speaker 2: prices have really kind of cooled down a little bit.
- 5:26Speaker 2: And that's something that you can also confirm from the
- 5:28Speaker 2: food inflation itself that we have received recently. And then
- 5:32Speaker 2: also for the exports, from the exports we have seen,
- 5:35Speaker 2: you know, one of our key markets in the Middle
- 5:38Speaker 2: East also opened up is a market for us to
- 5:41Speaker 2: re-export again sort of to continue with our exports. So
- 5:44Speaker 2: those are some of the positives because what has been
- 5:47Speaker 2: the issue is the fact that farmers have been taking
- 5:49Speaker 2: so much heat in terms of the losses. But now
- 5:51Speaker 2: with the slaughter numbers and then there's a little bit
- 5:55Speaker 2: increase in the movement of things, that is really helpful.
- 5:57Speaker 2: And that I can say that it's because of the
- 5:59Speaker 2: vaccines that are being put out. But the disease itself
- 6:02Speaker 2: is coming from over. Yeah, we've got a long way
- 6:04Speaker 2: to go. It's coming from over.
- 6:06Speaker 1: Yeah, but encouraging anyway. Tabile and Kunjana, thank you so much.
- 6:09Speaker 1: Agricultural economists. In fact, I love the way that you
- 6:12Speaker 1: say those sort of figures are up. It shows that
- 6:15Speaker 1: our farmers are making some headway at least.